BioAlliance announces positive preliminary results in the first Phase I clinical trial of fentanyl Lauriad® (PDF - 108 Ko)
Full-year accounts for 2009 (PDF - 72 Ko)
BioAlliance Pharma announces its consolidated turnover for 2009 - A doubling in recurring revenues (PDF - 49 Ko)
